On January 15, 2019, Dumas, Megan E.; Chen, Geng-Yuan; Kendrick, Nicole D.; Xu, George; Larsen, Scott A.; Jana, Somnath; Waterson, Alex G.; Bauer, Joshua A.; Hancock, William; Sulikowski, Gary A.; Ohi, Ryoma published an article.Name: 3-Bromo-5-fluoro-4-hydroxybenzaldehyde The title of the article was Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes. And the article contained the following:
The mitotic spindle is a microtubule-based machine that segregates a replicated set of chromosomes during cell division. Many cancer drugs alter or disrupt the microtubules that form the mitotic spindle. Microtubule-dependent mol. motors that function during mitosis are logical alternative mitotic targets for drug development. Eg5 (Kinesin-5) and Kif15 (Kinesin-12), in particular, are an attractive pair of motor proteins, as they work in concert to drive centrosome separation and promote spindle bipolarity. Furthermore, we hypothesize that the clin. failure of Eg5 inhibitors may be (in part) due to compensation by Kif15. In order to test this idea, we screened a small library of kinase inhibitors and identified GW108X, an oxindole that inhibits Kif15 in vitro. We show that GW108X has a distinct mechanism of action compared with a com. available Kif15 inhibitor, Kif15-IN-1 and may serve as a lead with which to further develop Kif15 inhibitors as clin. relevant agents. The experimental process involved the reaction of 3-Bromo-5-fluoro-4-hydroxybenzaldehyde(cas: 185345-46-4).Name: 3-Bromo-5-fluoro-4-hydroxybenzaldehyde
The Article related to kif15 eg5 oxindole kinesin inhibitors mitosis, eg5, kif15, kinesin, mitosis, oxindole, Pharmacology: Structure-Activity and other aspects.Name: 3-Bromo-5-fluoro-4-hydroxybenzaldehyde
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary